๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

โœ Scribed by McDermott, D. H.; Liu, Q.; Velez, D.; Lopez, L.; Anaya-O'Brien, S.; Ulrick, J.; Kwatemaa, N.; Starling, J.; Fleisher, T. A.; Priel, D. A. L.; Merideth, M. A.; Giuntoli, R. L.; Evbuomwan, M. O.; Littel, P.; Marquesen, M. M.; Hilligoss, D.; DeCastro, R.; Grimes, G. J.; Hwang, S. T.; Pittaluga, S.; Calvo, K. R.; Stratton, P.; Cowen, E. W.; Kuhns, D. B.; Malech, H. L.; Murphy, P. M.


Book ID
121532453
Publisher
American Society of Hematology
Year
2014
Tongue
English
Weight
529 KB
Volume
123
Category
Article
ISSN
0006-4971

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES